Webinar on role of tocotrienol vs. stroke injuries

EDISON, NJ, USA – Carotech Inc, the largest and only GMP-certified palm tocotrienol complex producer, is pleased to announce that a webinar on the neuroprotection properties tocotrienol presented by Prof. Chandan Sen, PhD will be held on December 6th, 11am, EST. The free webinar is now open for registration.

Dr Sen is professor of Surgery and executive director, Ohio State University Comprehensive Wound Center. With over 250 publications under his name, he is the author of the most cited work in tocotrienol, cited over 900 times a year in literature, and has extensively researched tocotrienols and neuroprotection since 2000. He is the editor-in-chief of the leading journal in redox biology, Antioxidants & Redox Signaling.

As the first researcher to study tocotrienols and neuroprotection, Professor Sen has spent more than a decade studying tocotrienols’ potent neuroprotection properties against stroke-induced injuries.  He receives research funding from the US government’s National Institute of Health (National Institute of Neurological Disorders and Stroke) and uses “Tocomin” and “Tocomin SupraBio” full spectrum palm tocotrienol complex from Carotech in his studies.

The Malaysian Palm Oil Council (MPOC) is the sponsor of this webinar session, which is a part of the palm fruit bioactives educational series launched since 2010.

“Everyone -- from consumer, researchers to members of the nutraceutical industry, must grab this opportunity to register for this webinar in order to learn first-hand how Tocomin SupraBio provides unique protection against stroke-related neuro injuries,” said  WH Leong, vice president, Carotech Inc.